Las patentes farmacéuticas de las vacunas contra el COVID-19 en contraposición al derecho a la salud en África: viabilidad de la exención del Acuerdo sobre los ADPIC

• Autores: Maria Hurtado Beneto
• Localización: Revista Boliviana de Derecho, ISSN-e 2070-8157, Nº. 35, 2023, págs. 386-413
• Idioma: español
• Títulos paralelos:
  • Pharmaceutical patents of covid-19 vaccines versus the right to health in africa: The feasibility of a trips waiver
• Enlaces
  • Texto completo (pdf)
• Resumen
  • español

    Este estudio examinará los aspectos positivos y negativos de la Decisión de derogación de ciertos aspectos del Acuerdo sobre los ADPIC en el contexto africano. Las bajas tasas de vacunación en el continente socavan el derecho de acceso a las vacunas, que forma parte del derecho humano a la salud previsto en el PIDESC. Sin embargo, sus potenciales beneficios deben ser estudiados considerando el desarrollo actual de la industria biotecnológica de los países africanos.

  • English

    This study will examine the positive and negative aspects of the Decision to repeal certain aspects of the TRIPS Agreement in the African context. Low vaccination rates on the continent undermine the right of access to vaccines, which is part of the human right to health under the ICESCR. However, its potential benefits should be studied in the light of the current development of the biotechnology industry in African countries.

• Referencias bibliográficas
  • “WHO Chief: Inequitable Vaccine Distribution is ‘Failure for Humanity”, VoaNews, 18 diciembre 2021.
  • Abiodun, T. et al.: “Vaccine Manufacturing in Africa: What It Takes and Why It Matters”, Blair Institute, 1 de abril 2021.
  • Acheampong, S. et al.: “Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link?”,...
  • Adepoju, P.: “Lack of orders could halt COVID-19 vaccine production in South Africa”, Devex, 14 de abril de 2022.
  • Agaba, D. K.: “Tackling inequality and governance challenges: Insights from the COVID-19 pandemic”, African Human Rights Law Journal, vol....
  • Akhtar, M.: “Is Covax finally going to vaccinate the world?”. Vox, 13 de enero de 2022.
  • Amnistía Internacional: “COVID-19. En n’assurant pas un accès équitable aux vaccins, les entreprises pharmaceutiques ont contribué à la catastrophe...
  • Anton, J., Greene, H. y Yao, D. A.: “Policy Implications of Weak Patent Rights”, Innovation Policy and the Economy, vol. 6, 2006.
  • Aoko, L.: “Africa in the lights of the Covid-19 pandemic: Health related Intellectual Property Rights”, Journal of Conflict, Management &...
  • Bathily, F.: “Covid: Aspenovax, le vaccin made in Africa boudé par l’Afrique”, Voa Afrique. 9 de mayo de 2022.
  • Binagwaho, A., Mathewos, K. y Davis, S.: “Equitable and Effective Distribution of the COVID-19 Vaccines - A Scientific and Moral Obligation”,...
  • Conway, M. et al.: “Should sub-Saharan Africa make its own drugs?”, McKinsey, 10 enero de 2019.
  • Eccleston-Turner, M. y Rourke, M.: “The TRIPS Waiver is Necessary, but it alone is not enough to solve equitable accces to Covid-19 vaccines”,...
  • Fortini, R. y Oyeyemi, O.: “Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study”, Pathogens...
  • Gavira, M. y Kilic, B.: “A network analysis of Covid-19 mRNA vaccine patents”, Nature biotechnology, 39, 2021.
  • Hassan, F.: “A New and Weak WTO Deal on TRIPS is Not Fit for Purpose: An ineffective multilateralism”, Thinking Global Health, 1 de julio...
  • Hilty, R. et al.: “10 Arguments against a waiver of intellectual property rights”, Bussiness Law Blog (BLB). 29 de junio 2021.
  • Hodgson, T. y de Falco, R.: “Human rights and universal access toCOVID-19 vaccines: does the human rights Council resolution go far enough?”,...
  • Hoen, E.: The Global Politics of Pharmaceutical Monopoly Power. Drug patents, access, innovation and the application of the WTO Doha Declaration...
  • Holzer, F. et al.: “A matter of priority: equitable access to COVID-19 vaccines”, Swiss Medical Weekly, vol. 151, 2021.
  • Holzer, F. et al.: “Charity or empowerment? The role of COVAX for low and middleincome countries”, Developing World Bioethics, 2022.
  • Human Rights Watch: “Universal and Equitable Access to Covid-19 Vaccines, Testing, Treatments: Companies’ Human Rights Responsibilities”,...
  • Hunt, P. y Khosla, R.: “The Human Right to Medicines”, Sur International Journal on Human Rights, vol. 8, 2008.
  • Ileyemi, M.: “COVID-19: Nigeria, five other African countries get WHO approval for vaccine production”. Premium Times, 18 de febrero de 2022.
  • Juno, J.: “Are new COVID variants like Omicron linked to low vaccine coverage?”, The Conversation, 29 de noviembre de 2021.
  • Kansteiner, F.: “Aspen Pharmacare, pursuing J&J vaccine license, aims to shore up local capacity and quash shot inequality in Africa”,...
  • Lamptey, E. et al.: “COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production”,...
  • López-Valcárcel, G.; Ortún V.; Peiro, S.: “A propósito de las vacunas Covid-19: Innovación, acceso y rol de las patentes”, Asociación de...
  • Manríquez, T. et al.: “Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines”, International journal of public health, vol....
  • Massinga, M. y Nkengasong, J.: “COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead”, Inmunity,...
  • Maxmen, A.: “The fight to manufacture COVID vaccines in lower-income countries”, Nature, vol. 597, núm. 7877, 2021.
  • Mazzouzi, R.: “Algeria Begins Producing a Coronavirus Vaccine”, Al Fanar Media, 22 de octubre 2021.
  • Médicos sin Fronteras: “Governments must demand pharma make all COVID-19 vaccine deals public”, 11 noviembre de 2020.
  • Motari, M. et al.: “The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement”,...
  • Mukherjee, P.: “Africa’s Aspen to supply its own branded COVID-19 vaccine by June”, Reuters Agency, 9 de marzo 2022.
  • Nguyen, A. y Schwalbe, N.: “Apples and oranges? Can second generation vaccines become as low cost as generic medicines?”, Vaccines, vol. 37,...
  • Niada, L.: “The human right to medicines in relation to patents in sub-Saharan Africa: some critical remarks”, The International Journal of...
  • Ortega, M.: “El derecho de acceso a los medicamentos y el derecho de patente en países en desarrollo”, Revista de Bioética y Derecho, vol....
  • Puyvallée, A. y Tagmatarchi K.: “COVAX, vaccine donations and the politics of global vaccine inequity”. Globalisation and Health, vol. 18,...
  • Razira, I.: “Access to Covid-19 vaccines: patents vs people?”, International and Comparative Law Review, vol. 21, núm. 1, 2021.
  • Schlein L.: “African Children Missing Out on Life-Saving Vaccines Due to COVID-19”, VoaNews, 22 abril 2022.
  • Sekalala, S. et al.: “Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine”, BMJ Global...
  • Thomson R., Hill, E. y Gog, J.: “SARS-CoV-2 incidence and vaccine escape”, The Lancet Infectious Diseases, vol. 21, 2021.
  • Uwishema, O. et al.: “Measles crisis in Africa amidst the COVID-19 pandemic: Delayed measles vaccine administration may cause a measles outbreak...
  • Vawda, Y.: “The TRIPS COVID-19 Waiver, Challenges for Africa and Decolonizing Intellectual Property”; South Center Policy Brief, núm. 99,...